D.E. Shaw & Co
AXNX

D.E. Shaw & Co’s Axonics, Inc. Common Stock AXNX Stock Holding History

D.E. Shaw & Co’s Portfolio AXNX Stock Details AXNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-3,325
Closed -$207K – 4837
2023
Q4 		$207K Sell
3,325
-568
-15% -$31.8K ﹤0.01% 3874
2023
Q3 		$218K Sell
3,893
-36,598
-90% -$2.06M ﹤0.01% 3731
2023
Q2 		$2.04M Sell
40,491
-160,148
-80% -$8.52M ﹤0.01% 2607
2023
Q1 		$10.9M Buy
200,639
+16,780
+9% +$980K 0.01% 1293
2022
Q4 		$11.5M Buy
183,859
+86,788
+89% +$5.76M 0.01% 1325
2022
Q3 		$6.84M Buy
+97,071
New +$6.7M 0.01% 1745
2021
Q4 		– Sell
-34,627
Closed -$2.25M – 5785
2021
Q3 		$2.25M Buy
+34,627
New +$2.36M ﹤0.01% 2932

Other funds holding AXNX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.76B AUM 62.41% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return

D.E. Shaw & Co's AXNX Position: Q1 2024 in Review

D.E. Shaw & Co sold out of Axonics, Inc. Common Stock (AXNX) in Q1 2024, closing a stake of 3,325 shares — an estimated $207K sold.

D.E. Shaw & Co first reported a position in AXNX in Q3 2021 and held it in 7 quarters. The position peaked at $11.5M in Q4 2022. 235 funds tracked by Wall St. Rank hold AXNX as of Q1 2024.

  • D.E. Shaw & Co reported no remaining Axonics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • D.E. Shaw & Co sold 3,325 Axonics, Inc. Common Stock shares in Q1 2024, an estimated $207K.
  • D.E. Shaw & Co first reported a position in Axonics, Inc. Common Stock in Q3 2021 and held it in 7 quarters.
  • D.E. Shaw & Co's Axonics, Inc. Common Stock position peaked at $11.5M in Q4 2022.
  • 235 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q1 2024.

Based on D.E. Shaw & Co's 13F filing for Q1 2024, filed 15 May 2024.